InvestSMART

Syntara Limited (ASX: SNT) - Announcements

- Current share price for SNT : $0.020

ASX company news and announcements for Syntara Limited (SNT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Syntara Limited (SNT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Syntara Limited (SNT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Syntara Limited (SNT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 Notification regarding unquoted securities - SNT 5 Oct 2026 2:24PM $0.021 $0.020 fallen by 4.76%
$39 Notification regarding unquoted securities - SNT 5 Oct 2026 2:21PM $0.021 $0.020 fallen by 4.76%
$39 Syntara expands SNT-9465 skin scarring study 1 Oct 2026 9:49AM $0.022 $0.020 fallen by 9.09%
$39 Syntara receives A$4.7m R&D Tax Incentive 21 Sep 2026 8:45AM $0.023 $0.020 fallen by 13.04%
$39 Application for quotation of securities - SNT 15 Sep 2026 10:01AM $0.024 $0.020 fallen by 16.67%
$39 Notification of 2026 AGM Date 15 Sep 2026 9:58AM $0.024 $0.020 fallen by 16.67%
$39 Appendix 4G and Corporate Governance Statement 27 Aug 2026 2:50PM $0.027 $0.020 fallen by 25.93%
$39 Appendix 4E and Annual Report 27 Aug 2026 2:49PM $0.027 $0.020 fallen by 25.93%
$39 Investor Update Webinar Presentation 28 Jul 2026 11:01AM $0.023 $0.020 fallen by 13.04%
$39 Investor Update Webinar 27 Jul 2026 9:56AM $0.022 $0.020 fallen by 9.09%
$39 Investor Presentation 27 Jul 2026 9:26AM $0.022 $0.020 fallen by 9.09%
$39 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 9:18AM $0.022 $0.020 fallen by 9.09%
$39 AZALOX MDS study advances to final Phase 1b cohort 20 Jul 2026 10:01AM $0.023 $0.020 fallen by 13.04%
$39 SNT-4728 Webinar Presentation 6 Jul 2026 1:13PM $0.024 $0.020 fallen by 16.67%
$39 Encouraging SNT-4728 Phase 2 iRBD results 6 Jul 2026 9:43AM $0.023 $0.020 fallen by 13.04%
$39 Trading Halt 3 Jul 2026 9:23AM $0.023 $0.020 fallen by 13.04%
$39 Notification regarding unquoted securities - SNT 2 Jul 2026 3:14PM $0.023 $0.020 fallen by 13.04%
$39 Application for quotation of securities - SNT 2 Jul 2026 2:59PM $0.022 $0.020 fallen by 9.09%
$39 Proposed issue of securities to the CEO 2 Jul 2026 2:56PM $0.022 $0.020 fallen by 9.09%
$39 SNT-9465 scarring trial exceeds 50% enrolment 1 Jul 2026 10:01AM $0.021 $0.020 fallen by 4.76%
$39 Change in substantial holding 30 Jun 2026 9:36AM $0.020 $0.020 fallen by 0%
$39 Section 708A(5)(e) notice 25 Jun 2026 9:18AM $0.023 $0.020 fallen by 13.04%
$39 Application for quotation of securities - SNT 25 Jun 2026 9:12AM $0.023 $0.020 fallen by 13.04%
$39 Results of Meeting 23 Jun 2026 2:23PM $0.023 $0.020 fallen by 13.04%
$39 Application for quotation of securities - SNT 11 Jun 2026 9:13AM $0.025 $0.020 fallen by 20%

1 - 25 of 280 results

Page 1 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.